ArticleActa veterinaria Scandinavica2025
Clinical features, diagnostic findings, and treatment response in Finnish horses examined for equine inflammatory bowel disease.
Article in Acta veterinaria Scandinavica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Five Domains, Multiple Realities: A Multidimensional Analysis of Equine Welfare in Equestrian Events in Brazil.Animals : an open access journal from MDPI · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEquine inflammatory bowel disease (IBD) is challenging to diagnose and treat. Although the number of horses examined due to suspicion of IBD is increasing, the different treatments in clinical patients and their responses are not well documented. We sought to characterize the demography, signs, clinical and rectal biopsy findings, and treatment response in Finnish horses suspected to have IBD. Horses undergoing clinical examination due to suspected IBD in 2022 and with a good-quality rectal biopsy were selected for the study. General information, signs, clinical and histological findings, and treatment response were collected retrospectively from owners and participating clinics. The effect of variables on symptoms, treatment response, and biopsy results was assessed using statistical methods (significance level P < 0.05).
resultsA total of 152 horses was included. The most common signs were poor performance (68%), nonspecific pain (43%), and irritation/aggression (41%). Intestinal signs were observed in 63% of horses. Sixty-six percent of horses had ultrasonographic changes in the small intestine, and 37% had gastric ulcers. Orthopaedic examination was mentioned in 12% of horses. In rectal biopsy, horses had eosinophilic (35%), lymphoplasmacytic (18%), or neutrophilic (6%) inflammation; 40% had no inflammation. Inflammation was observed mostly in horses aged 5-8 years (P = 0.015). Changes in rectal biopsy were associated with certain behaviour changes (P = 0.002). Sixty-eight percent of horses were treated with medication and dietary change. Glucocorticoids were first-line treatment in 73% of medicated horses. Medication was changed during treatment in 35 horses. Treatment response was considered good in 49% of horses. Access to pasture was associated with a reduction in signs (P = 0.001). Signs, clinical and biopsy findings, and treatment type were not associated with treatment response. Medication change was associated with poorer treatment response.
conclusionsMost horses had at least a partial positive treatment response. Investment in pasture-like management, forage, and exercise regimen may be helpful during out-of-pasture season. Performance issues and nonspecific behaviour changes should be included as possible IBD-related signs, but a more structured clinical diagnostic workup is needed for a reliable assessment of treatment response and to increase the diagnostic value of rectal biopsy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.